期刊
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 106, 期 11, 页码 E4542-E4553出版社
ENDOCRINE SOC
DOI: 10.1210/clinem/dgab461
关键词
anti-Mullerian hormone; breast cancer risk factors; AMH correlates
资金
- National Institutes of Health (NIH) [R01 CA178949]
- Breast Cancer Now
- Institute of Cancer Research, United Kingdom
- National Health System
- Institute of Cancer Research NIHR Biomedical Research Centre
- Intramural Research Program of the NIH, National Cancer Institute (NCI)
- Department of Defense Breast Cancer Research Program [BC062367]
- Cancer Research United Kingdom [C570/A16491]
- New York University Women's Health Study (NYUWHS) [NIH R01 CA098661, UM1 CA182934, P30 CA016087, P30 ES000260]
- Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01-ES044005]
- Avon Foundation [02-2012-085]
- [NCI UM1 CA186107]
- [R01 CA49449]
- [NCI UM1 CA176726]
- [R01 CA67262]
This study found positive associations between AMH and age at menarche and parity, and negative associations with hysterectomy/partial oophorectomy. Women who were obese, currently used oral contraceptives, or were current/former smokers had lower AMH concentrations. Interestingly, higher AMH concentrations were observed in women who had a benign breast biopsy, especially in women over 40 years old.
Context: We previously reported that anti-Mullerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies. Objective: This study assessed whether risk factors for breast cancer are correlates of AMH concentration. Methods: This cross-sectional study included 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49) from 10 cohort studies among the general population. Results: Adjusting for age and cohort, AMH positively associated with age at menarche (P<0.0001) and parity (P=0.0008) and inversely associated with hysterectomy/partial oophorectomy (P=0.0008). Compared with women of normal weight, AMH was lower (relative geometric mean difference 27%, P<0.0001) among women who were obese. Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P<0.0001). We observed higher AMH concentrations among women who had had a benign breast biopsy (15% higher, P=0.03), a surrogate for benign breast disease, an association that has not been reported. In analyses stratified by age (<40 vs >= 40), associations of AMH with body mass index and OCs were similar in younger and older women, while associations with the other factors (menarche, parity, hysterectomy/partial oophorectomy, smoking, and benign breast biopsy) were limited to women >= 40 (P-interaction <0.05). Conclusion: This is the largest study of AMH and breast cancer risk factors among women from the general population (not presenting with infertility), and it suggests that most associations are limited to women over 40, who are approaching menopause and whose AMH concentration is declining.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据